Loading...
Understand KRAS and the Quest for Anti-Cancer Drugs
The KRAS oncogene is mutated in approximately ~30% of human cancers, and the targeting of KRAS has long been highlighted in many studies. Nevertheless, attempts to target KRAS directly have been ineffective. This review provides an overview of the structure of KRAS and its characteristic signaling p...
Saved in:
| Published in: | Cells |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8068306/ https://ncbi.nlm.nih.gov/pubmed/33917906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10040842 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|